Neurovirulence Test of Types 1, 2 or 3 Live attenuated Poliomyelitis vaccines (Oral) in Transgenic Mice susceptible to Poliovirus
Standard Operating Procedure, Version 7
6 November 2015
| Meeting report
WHO Team
Norms and Standards for Biological Products (NSB)
Number of pages
39
Copyright
World Health Organization